Production and Evaluation of an Evidence-based Health Awareness Video on Precautionary Measures Against Respiratory Infectious Diseases (HAV-RID Study)
NCT ID: NCT07248319
Last Updated: 2025-11-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
160 participants
INTERVENTIONAL
2026-03-01
2028-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mobile Application for Prescription Drug-Abuse Education (MAPDE)
NCT03165175
VEText Message Framing and Covid-19 Vaccine Uptake Among at Risk Veterans
NCT04805931
Use of a Training Video to Teach Medical Students About Health Literacy
NCT01460953
Physician Awareness of Patients' Preferred Level of Involvement in Decision Making
NCT05314959
COVID-19 Vaccine Text Outreach
NCT04834726
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aim: The aim of this study is to produce and evaluate an evidence-based health awareness video on precautionary measures against RID among public transportation drivers in Lebanon.
Methods: This project will be conducted over three stages and executed over two fiscal years (start date March 2026).
Stage one: Drafting the script of the video is inspired by seven published / unpublished evidence-based studies on public transportation drivers in Lebanon and fourteen studies from international literature. This ensures the video content is evidence-based, culturally oriented, socially acceptable and tailored towards the target viewers.
Stage two: Using a Delphi technique, the script will be revised by a panel of eight experts in public health, infection control, psychology, filmmaking, and public transportation using two validated assessment tools, the Patient Education Materials Assessment Tool (PEMAT) and DISCERN. A purposive sampling method will be followed. Once consensus is reached, the video will be produced.
Stage three: Non-blinded, randomized, two-arm controlled trial will be conducted by a group of senior nursing students (minimal risk study). Public transportation drivers are eligible to enroll if they operate within the Lebanese public transportation system, regardless of their gender. A proportionate sample of drivers will be invited to enroll from various Lebanese regions. Simple randomization technique will be performed. The experimental group (n=80) will watch the health-awareness video, whereas the control group (n=80) will watch a neutral video on traffic signs. Participants' knowledge about RID, health-risk perceptions, attitude towards vaccination, and cognitive dissonance will be evaluated. The trial study will be conducted in community settings where public transportation drivers are naturally present (transportation stations, parking lots). A written informed consent will be sought. Data will be electronically recorded. Data will remain anonymous during data entry/analyses. An incentive will be provided.
Data analysis: Data will be analyzed using SPSS; IBM (version 30). Knowledge statements will be scored and converted to percentage mean score. Risk perceptions, attitude and dissonance will be scored and converted to mean scores. Between group analyses of mean differences will be tested using student t-test and one way analysis of variance (ANOVA) with post hoc analysis (for normally distributed data) and Kruskall Wallis test with post hoc analysis (for skewed data). Forward stepwise linear regression analyses will be executed. Statistical significance will be at P\<0.05 (two sided). Interim analysis will be performed at n=40.
Expected outcomes: Public transportation drivers and users might be unknowingly exposed to RID, so promoting their safety is a priority. When public transportation drivers are exposed to a video on RID, they will gain knowledge about it and demonstrate a positive attitude towards precautionary measures. This video contributes to higher service satisfaction and subsequently higher utilization of the transportation system. Utilizing the public transportation systems reduces street congestions, controls pollution, saves money for users and generates profits for stakeholders. Promoting a safe public transportation system reflects positively on public health, aligns with the CDC mission to control the global spread of diseases and lessens disease burden. Last but not least, health awareness videos are cost effective and they can reach a wider audience.
Ethical considerations: This study will not pose any risk or harm to participants. The video will not contain any material that might offend, insult, degrade, or discriminate against study participants in any way possible. Medical jargon and complex terms will be avoided. The video will be concluded with contact information in case participants decided to consult with experts in the future. Data collectors will be trained on how to remedy their concerns through cognitive behavioral therapy techniques to resolve negative thoughts, guide them on sources of knowledge and places to obtain facemasks, hand sanitizers and vaccines. Last but not least, participants will not be asked for any ID. The decision to participate or not will have no impact on drivers.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group (n=80) will watch the health-awareness video
The experimental group will watch the newly produced health-awareness video. Using a Delphi technique, the script will be revised by a panel of experts in public health, infection control, psychology, filmmaking, and public transportation (drivers, users, stakeholders). Experts will evaluate the script using two validated assessment tools, the Patient Education Materials Assessment Tool (PEMAT) and DISCERN. Once consensus is reached, the video will be produced.
Health awareness video on precautionary measures against respiratory infectious disease
Drafting of a narrative blueprint of the script for the health-awareness video is inspired by published and unpublished evidence-based studies previously conducted on public transportation drivers in Lebanon. This ensures the video content is evidence-based, culturally oriented, socially acceptable and tailored towards the target viewers. Using a Delphi technique, the script will be revised by a panel of experts in public health, infection control, psychology, filmmaking, and public transportation (drivers, users, stakeholders). Experts will evaluate the script using two validated assessment tools, the Patient Education Materials Assessment Tool (PEMAT) and DISCERN. Once consensus is reached, the video will be produced.
control group will watch a neutral video
control group will watch a neutral video (raising awareness about traffic signs in Lebanon, https://www.youtube.com/watch?v=hb3107sylj0 )
Health awareness video on precautionary measures against respiratory infectious disease
Drafting of a narrative blueprint of the script for the health-awareness video is inspired by published and unpublished evidence-based studies previously conducted on public transportation drivers in Lebanon. This ensures the video content is evidence-based, culturally oriented, socially acceptable and tailored towards the target viewers. Using a Delphi technique, the script will be revised by a panel of experts in public health, infection control, psychology, filmmaking, and public transportation (drivers, users, stakeholders). Experts will evaluate the script using two validated assessment tools, the Patient Education Materials Assessment Tool (PEMAT) and DISCERN. Once consensus is reached, the video will be produced.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Health awareness video on precautionary measures against respiratory infectious disease
Drafting of a narrative blueprint of the script for the health-awareness video is inspired by published and unpublished evidence-based studies previously conducted on public transportation drivers in Lebanon. This ensures the video content is evidence-based, culturally oriented, socially acceptable and tailored towards the target viewers. Using a Delphi technique, the script will be revised by a panel of experts in public health, infection control, psychology, filmmaking, and public transportation (drivers, users, stakeholders). Experts will evaluate the script using two validated assessment tools, the Patient Education Materials Assessment Tool (PEMAT) and DISCERN. Once consensus is reached, the video will be produced.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Drivers who are unwilling to enroll in the study or unable to comprehend written/verbal Arabic language will be excluded.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lebanese American University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mahmoud Salam
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mahmoud Salam, PhD
Role: PRINCIPAL_INVESTIGATOR
Lebanese American University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mahmoud Salam
Beirut, , Lebanon
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Risk perceptions towards respiratory infectious diseases among university students utilizing the public transportation system in Lebanon
Salam M, Haidar GH. Influenza vaccine hesitancy and its determinants among Lebanese public transportation drivers. Vaccine X. 2024 Dec 25;22:100606. doi: 10.1016/j.jvacx.2024.100606. eCollection 2025 Jan.
Exploring the Challenges that Public Transportation Drivers Face in Lebanon
COVID-19 risk perceptions among public transportation drivers and users in Lebanon: A cross-sectional study
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LAU.SON.MS1.18/Dec/2025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.